Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
Maria Lina Tornesello, Luigi Buonaguro, Fabiana Tatangelo, et al.
Genomics (2013) Vol. 102, Iss. 2, pp. 74-83
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Ying Jiang, Aihua Sun, Yang Zhao, et al.
Nature (2019) Vol. 567, Iss. 7747, pp. 257-261
Closed Access | Times Cited: 750
Wnt–β-catenin signalling in liver development, health and disease
María J. Perugorria, Paula Olaizola, Ibone Labiano, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 2, pp. 121-136
Closed Access | Times Cited: 454
The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
Viktoriia A. Arzumanian, Olga I. Kiseleva, Ekaterina V. Poverennaya
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13135-13135
Open Access | Times Cited: 212
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Obesity-associated mechanisms of hepatocarcinogenesis
Raffi Karagozian, Zoltán Derdák, György Baffy
Metabolism (2014) Vol. 63, Iss. 5, pp. 607-617
Closed Access | Times Cited: 164
Genetic alterations in hepatocellular carcinoma: An update
Zhao-Shan Niu, Xiao-Jun Niu, Wenhong Wang
World Journal of Gastroenterology (2016) Vol. 22, Iss. 41, pp. 9069-9069
Open Access | Times Cited: 151
Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials
Richard Jackson, Eftychia‐Eirini Psarelli, Sarah Berhane, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 6, pp. 622-628
Closed Access | Times Cited: 146
Targeting Wnts at the Source—New Mechanisms, New Biomarkers, New Drugs
Babita Madan, David M. Virshup
Molecular Cancer Therapeutics (2015) Vol. 14, Iss. 5, pp. 1087-1094
Open Access | Times Cited: 105
Genomic insights into WNT/β-catenin signaling
Joseph Rosenbluh, Xiaoxing Wang, William C. Hahn
Trends in Pharmacological Sciences (2013) Vol. 35, Iss. 2, pp. 103-109
Open Access | Times Cited: 103
Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity
Hua Tan, Jiguang Bao, Xiaobo Zhou
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 98
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
Xiaoxiao Ding, Qing-Ge Zhu, Shiming Zhang, et al.
Oncotarget (2017) Vol. 8, Iss. 33, pp. 55715-55730
Open Access | Times Cited: 88
miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features
Yuanzhuo Gu, Xiyang Wei, Yulin Sun, et al.
Cancer Research (2018) Vol. 79, Iss. 5, pp. 941-953
Open Access | Times Cited: 85
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, et al.
Cancer Letters (2024) Vol. 597, pp. 217061-217061
Closed Access | Times Cited: 9
Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma
Anna Wójcicka, Michał Świerniak, Oskar Kornasiewicz, et al.
The International Journal of Biochemistry & Cell Biology (2014) Vol. 53, pp. 208-217
Closed Access | Times Cited: 91
Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
Fei He, Jie Li, Jianfeng Xu, et al.
Journal of Experimental & Clinical Cancer Research (2015) Vol. 34, Iss. 1
Open Access | Times Cited: 89
Multiple interactive factors in hepatocarcinogenesis
Jin Ding, Hongyang Wang
Cancer Letters (2013) Vol. 346, Iss. 1, pp. 17-23
Closed Access | Times Cited: 88
A Small-Molecule Modulator of the Tumor-Suppressor miR34a Inhibits the Growth of Hepatocellular Carcinoma
Zhangang Xiao, Chi Han Li, Stephen L. Chan, et al.
Cancer Research (2014) Vol. 74, Iss. 21, pp. 6236-6247
Open Access | Times Cited: 81
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
Maria Lina Tornesello, Clorinda Annunziata, Anna Lucia Tornesello, et al.
Cancers (2018) Vol. 10, Iss. 7, pp. 213-213
Open Access | Times Cited: 80
Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma
Wenhui Wang, Qiuwei Pan, Gwenny M. Fuhler, et al.
Journal of Gastroenterology (2016) Vol. 52, Iss. 4, pp. 419-431
Open Access | Times Cited: 79
Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform†
Kirk J. Wangensteen, Yue J. Wang, Zhixun Dou, et al.
Hepatology (2017) Vol. 68, Iss. 2, pp. 663-676
Open Access | Times Cited: 77
Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
Maria Lina Tornesello, Luigi Buonaguro, Francesco Izzo, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 25087-25102
Open Access | Times Cited: 75
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
Marianna Alunni‐Fabbroni, Kerstin Rönsch, Thomas S. Huber, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 66
Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma
Francesca Pezzuto, Francesco Izzo, Luigi Buonaguro, et al.
Oncotarget (2016) Vol. 7, Iss. 34, pp. 54253-54262
Open Access | Times Cited: 64
The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
Francesca Pezzuto, Luigi Buonaguro, Franco M. Buonaguro, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1007-1007
Open Access | Times Cited: 59
Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma
Mi Jeong Heo, Jessica Yun, Sang Geon Kim
Archives of Pharmacal Research (2019) Vol. 42, Iss. 1, pp. 48-62
Closed Access | Times Cited: 58
Page 1 - Next Page

Scroll to top